ArticleAdvances in therapy2021

CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.

Liang Dai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.